Greenwich LifeSciences, Inc. - COM (GLSI)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM
Total 13F shares
259,549
Share change
+147,596
Total reported value
$8,889,000
Price per share
$34.12
Number of holders
18
Value change
+$5,018,995
Number of buys
12
Number of sells
6

Institutional Holders of Greenwich LifeSciences, Inc. - COM (GLSI) as of Q1 2021

As of 31 Mar 2021, Greenwich LifeSciences, Inc. - COM (GLSI) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 259,549 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, HRT FINANCIAL LP, JACOBS LEVY EQUITY MANAGEMENT, INC, SkyOak Wealth, LLC, Creative Planning, CITADEL ADVISORS LLC, and MORGAN STANLEY. This page lists 19 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.